Fattah A S, Nakama H, Kamijo N, Fujimori K, Zhang B
Department of Public Health, Shinshu University School of Medicine, Nagano, Japan.
Hepatogastroenterology. 1998 May-Jun;45(21):712-6.
BACKGROUND/AIMS: This study aimed to evaluate the validity of immuno-chemical occult blood screening for colorectal adenomas and to clarify the characteristics of this disease which are detected.
We studied 140 colorectal adenomas and 140 healthy controls in a hospital based case control study, in which three-day testing was conducted to assess the accuracy of the immuno-chemical occult blood screening test (total 280 patients). A further 80 colorectal adenomas 1 cm or larger, which were detected by a screening program, were compared with matched cases detected by the outpatient clinics (total 160 patients). A comparison of characteristics including tumor location, shape and histology was made between the two groups.
Sensitivity and specificity were calculated to be 46% (61% for tumors larger than 1 cm, 30% for those less than 1 cm), and 96% respectively, showing a significant difference in sensitivity between large and small adenomas (p < 0.01). The proportion of rectal adenomas was significantly higher in the outpatient clinics (41%) than in the screening program (21%) (p < 0.05), whereas no differences were noted in the other measures.
These results suggest that immuno-chemical occult blood is inadequate as a screening test for detecting small adenomas, as t can not differentiate between the detection of rectal adenomas from large adenomatous polyps.
背景/目的:本研究旨在评估免疫化学隐血筛查对结直肠腺瘤的有效性,并阐明所检测到的该疾病的特征。
我们在一项基于医院的病例对照研究中对140例结直肠腺瘤患者和140例健康对照者进行了研究,其中进行了为期三天的检测以评估免疫化学隐血筛查试验的准确性(总共280例患者)。将通过筛查程序检测出的另外80例直径1厘米或更大的结直肠腺瘤与门诊检测出的匹配病例进行比较(总共160例患者)。对两组之间包括肿瘤位置、形状和组织学在内的特征进行了比较。
计算得出敏感性和特异性分别为46%(直径大于1厘米的肿瘤为61%,小于1厘米的为30%)和96%,表明大小腺瘤之间的敏感性存在显著差异(p < 0.01)。门诊患者中直肠腺瘤的比例(41%)显著高于筛查程序中的比例(21%)(p < 0.05),而在其他指标上未发现差异。
这些结果表明,免疫化学隐血作为检测小腺瘤的筛查试验并不充分,因为它无法区分直肠腺瘤和大腺瘤性息肉的检测结果。